Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Marc E. Binda [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 17, 2026, Marc E. Binda, our Chief Financial Officer and Treasurer, terminated a Rule 10b5-1 trading arrangement that he had previously adopted in December 2025 for the sale from time to time of up to 23,368 shares of common stock. The trading arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled to expire on December 1, 2026.
|
| Name | Marc E. Binda |
| Title | Chief Financial Officer and Treasurer |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | June 17, 2026 |
| Expiration Date | December 1, 2026 |
| Aggregate Available | 23,368 |
| Hallie E. Kuhn [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 18, 2026, Hallie E. Kuhn, our Executive Vice President – Capital Markets and Co-Lead – Life Science, terminated a Rule 10b5-1 trading arrangement that she had previously adopted in December 2025 for the sale from time to time of up to 2,574 shares of common stock. The trading arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled to expire on October 16, 2026. On June 25, 2026, Hart Cole, our Co-President & Co-Regional Market Director – Seattle, terminated a Rule 10b5-1 trading arrangement that he had previously adopted in December 2025 for the sale from time to time of up to 20,000 shares of common stock. The trading arrangement was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and was scheduled to expire on January 29, 2027.
|
| Name | Hallie E. Kuhn |
| Title | Executive Vice President – Capital Markets and Co-Lead – Life Science |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | June 18, 2026 |
| Expiration Date | October 16, 2026 |
| Aggregate Available | 2,574 |
| Hart Cole [Member] | |
| Trading Arrangements, by Individual | |
| Name | Hart Cole |
| Title | Co-President & Co-Regional Market Director – Seattle |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | June 25, 2026 |
| Expiration Date | January 29, 2027 |
| Aggregate Available | 20,000 |